Does betahistine cause tinnitus (ringing in the ears)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Betahistine does not typically cause tinnitus; in fact, it is often prescribed to treat tinnitus and vertigo associated with Ménière's disease. According to the most recent and highest quality study, the BEMED trial 1, betahistine was found to have no significant effect on the mean number of vertigo attacks related to Ménière's disease compared to placebo, but it is still used to alleviate symptoms of tinnitus and vertigo. The medication works by improving microcirculation in the inner ear and reducing endolymphatic pressure, which can help alleviate existing tinnitus symptoms.

Key Points to Consider

  • Betahistine is a histamine analog that primarily affects H1 and H3 receptors, improving blood flow to the inner ear structures 1.
  • Some patients may experience mild side effects like headache, upset stomach, or allergic reactions, but tinnitus is not a commonly reported adverse effect 1.
  • If someone experiences new or worsening tinnitus while taking betahistine, they should consult their healthcare provider as it may indicate an underlying condition or a need to adjust treatment.
  • The BEMED trial 1 is a well-designed study that provides the best evidence available, and its findings suggest that betahistine may not be effective in reducing vertigo attacks, but it can still be used to treat tinnitus and other symptoms of Ménière's disease.

Treatment and Management

  • Betahistine is usually prescribed at doses of 8-16 mg taken three times daily, with treatment often continuing for several months 1.
  • Patients should be reassessed as often as clinically warranted for an improvement or stabilization of symptoms as well as to monitor for intolerance of medication or side effects 1.
  • The clinician and patient should discuss titrating down or stopping the medication once the patient’s symptoms subside 1.

From the Research

Betahistine and Tinnitus

  • The relationship between betahistine and tinnitus is complex, with some studies suggesting a potential benefit and others finding no significant effect 2, 3, 4.
  • A 2018 Cochrane review found that betahistine had no significant effect on tinnitus loudness or symptom severity compared to placebo, with very low-quality evidence 2.
  • In contrast, a 2011 study found that betahistine significantly improved tinnitus in patients with vestibular disorders, with 30.5% of patients experiencing clinical improvement 3.
  • Other studies have found that betahistine may be useful in reducing vertigo attacks in patients with Menière's disease, but its effect on tinnitus is less clear 5, 6.

Adverse Effects

  • Betahistine is generally well-tolerated, with a similar risk of adverse effects to placebo treatments 2, 4.
  • Common adverse effects reported in studies include upper gastrointestinal discomfort, headache, drowsiness, and allergic skin reactions 2, 3.

Study Limitations

  • Many studies on betahistine and tinnitus have methodological limitations, including small sample sizes, inadequate diagnostic criteria, and bias in methods 2, 4.
  • Further research is needed to fully understand the effects of betahistine on tinnitus, using rigorous methodology and validated outcome measures 2, 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Betahistine for tinnitus.

The Cochrane database of systematic reviews, 2018

Research

Betahistine in the treatment of tinnitus in patients with vestibular disorders.

Brazilian journal of otorhinolaryngology, 2011

Research

Betahistine for Menière's disease or syndrome.

The Cochrane database of systematic reviews, 2001

Research

Report from a Consensus Conference on the treatment of Ménière's disease with betahistine: rationale, methodology and results.

Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.